0 Kommentare
0 Geteilt
2KB Ansichten
0 Bewertungen
Suche
Entdecken Sie neue Leute, knüpfen Sie neue Kontakte und schließen Sie neue Freundschaften
-
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
-
Companion Diagnostics Market Trends in Molecular Biomarker TestingThe companion diagnostics market is becoming an increasingly important link between diagnosis and treatment. Instead of asking only whether a disease is present, modern healthcare is increasingly asking a more specific question: which therapy is most appropriate for this patient? That change is reshaping the role of diagnostics. A biomarker can now influence whether a targeted drug is...0 Kommentare 0 Geteilt 263 Ansichten 0 Bewertungen
-
Advances in Biomarker-Based Diagnostics Are Transforming the Calprotectin Testing IndustryThe increasing prevalence of inflammatory bowel disease (IBD), growing demand for non-invasive diagnostic tools, and rising awareness of early gastrointestinal disease detection are driving the growth of the calprotectin testing market. However, the market also faces several challenges. High testing costs, limited reimbursement in certain healthcare systems, variability in test...0 Kommentare 0 Geteilt 264 Ansichten 0 Bewertungen
-
Biomarker Detection Kits and Multiplex Immunoassays: Revolutionizing Clinical DiagnosticsIn the realm of clinical diagnostics, few areas have seen as much progress and innovation as the development of biomarker detection kits. The evolution of these kits has been a game-changer, transforming what was once a time-consuming, sample-intensive process into a highly efficient, information-rich analytical approach. Central to this transformation are Biomarker Detection Kits ,...0 Kommentare 0 Geteilt 314 Ansichten 0 Bewertungen
-
Cystatin C Testing Market: Renal Biomarker Testing and Clinical Diagnostics to 2034The Cystatin C Testing Market is gaining importance as healthcare providers increasingly seek sensitive, reliable biomarkers to evaluate kidney function. Cystatin C is a low-molecular-weight protein produced by cells throughout the body and filtered by the kidneys, making it useful for assessing glomerular filtration. Compared with conventional kidney-function assessments, cystatin C testing...0 Kommentare 0 Geteilt 172 Ansichten 0 Bewertungen
-
Europe Ovarian Cancer Diagnostics Market Size, Share, Biomarker Trends and Strategic Forecast 2032"Executive Summary Europe Ovarian Cancer Diagnostics Market Size and Share Analysis Report Data Bridge Market Research analyses that the market is growing with a CAGR of 6.5% in the forecast period of 2023 to 2030 and is expected to reach USD 3,093.84 million by 2030 from USD 1,874.16 million in 2022. the Europe Ovarian Cancer Diagnostics Market analysis report, the strength and...0 Kommentare 0 Geteilt 912 Ansichten 0 Bewertungen
-
Lung Cancer Diagnostics Kit Market – Advancing Early Detection Through Molecular and Biomarker TestingMarket Overview The lung cancer diagnostics kit market is expanding as clinical laboratories increasingly adopt molecular and biomarker-based testing to enable earlier, more precise lung cancer detection and treatment selection. Diagnostic kits spanning liquid biopsy, genetic mutation panels, and protein biomarker assays support both initial diagnosis and ongoing treatment monitoring. The Lung...0 Kommentare 0 Geteilt 374 Ansichten 0 Bewertungen
-
Renal Biomarker Market: Early Detection Trends in AKI and CKD, AI-Enabled Diagnostics, and Clinical Research Applications"Future of Executive Summary Renal Biomarker Market: Size and Share Dynamics Data Bridge Market Research analyses that the renal biomarker market is expected to reach the value of USD 508.34 million by the year 2029, at a CAGR of 7.70% during the forecast period. A DBMR team of experts and professionals from a number of streams and verticals bring along crucial tried-and-tested skills,...0 Kommentare 0 Geteilt 1KB Ansichten 0 Bewertungen
-
Adrenal Cancer Diagnostics Market Size and Revenue Forecast to 2030According to the latest report published by Data Bridge Market Research, the Adrenal Cancer Diagnostics Market Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as...0 Kommentare 0 Geteilt 2KB Ansichten 0 Bewertungen
-
Adrenal Cancer Diagnostics Market Size, Share and Trends Forecast to 2030According to the latest report published by Data Bridge Market Research, the Adrenal Cancer Diagnostics Market Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as...0 Kommentare 0 Geteilt 10KB Ansichten 0 Bewertungen
-
Adrenal Cancer Diagnostics Market Size, Share, and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Adrenal Cancer Diagnostics Market Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as...0 Kommentare 0 Geteilt 4KB Ansichten 0 Bewertungen
-
Asia-Pacific Genetic Testing Market Size, Share and Forecast Report to 2029According to the latest report published by Data Bridge Market Research, the Asia-Pacific Genetic Testing Market Asia-Pacific genetic testing market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2022 to 2029 and is expected to reach USD 11,255.30...0 Kommentare 0 Geteilt 11KB Ansichten 0 Bewertungen
-
Asia-Pacific Multiplex Assays Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Asia-Pacific Multiplex Assays Market The Asia-Pacific multiplex assays market size was valued at USD 750.50 million in 2024 and is expected to reach USD 1,562.55 million by 2032, at a CAGR of 9.6% during the forecast period Attaining maximum return on investment (ROI) is...0 Kommentare 0 Geteilt 3KB Ansichten 0 Bewertungen
-
Asia-Pacific Multiplex Assays Market Size, Share and Trends Forecast to 2032According to the latest report published by Data Bridge Market Research, the Asia-Pacific Multiplex Assays Market The Asia-Pacific multiplex assays market size was valued at USD 750.50 million in 2024 and is expected to reach USD 1,562.55 million by 2032, at a CAGR of 9.6% during the forecast period The market research studies of Asia-Pacific Multiplex...0 Kommentare 0 Geteilt 3KB Ansichten 0 Bewertungen
-
Autoimmune Disease Diagnostics Market Sees Momentum From Personalized TestingThe autoimmune disease diagnostics market is gaining momentum as the growing burden of autoimmune disorders increases demand for early, accurate, and efficient disease detection. The market was valued at USD 6.1 billion in 2025 and is estimated to reach USD 6.4 billion in 2026. It is projected to expand to USD 9.6 billion by 2033, registering a CAGR of 5.8% from 2026 to 2033. The increasing...0 Kommentare 0 Geteilt 85 Ansichten 0 Bewertungen
-
Biomarker-Based Testing Gains Importance Across the Cancer Care JourneyThe cancer biomarkers market is entering a period of strong expansion as rising cancer cases, increasing emphasis on early diagnosis, and growing adoption of personalized treatment continue to reshape oncology care. According to Grand View Research, the market size was valued at USD 26.9 billion in 2025 and is projected to increase from USD 29.9 billion in 2026 to USD 65.3 billion by 2033,...0 Kommentare 0 Geteilt 882 Ansichten 0 Bewertungen
-
Clinical LC-MS Market to Reach USD 1.69 Billion by 2031 | CAGR 7.4%According to a newly published market research report by 24LifeSciences, global clinical LC-MS market was valued at USD 1.03 billion in 2024 and is projected to reach USD 1.69 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period 2025-2031. Liquid chromatography-mass spectrometry (LC-MS), clinically known as the gold standard for clinical...0 Kommentare 0 Geteilt 2KB Ansichten 0 Bewertungen
-
Companion Diagnostics Market Could Double as Targeted Therapy Adoption RisesThe companion diagnostics market is becoming increasingly important as healthcare moves from broad treatment approaches toward precision medicine and biomarker-guided therapies. The market was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, registering a CAGR of 10.1% from 2026 to 2033. Increasing demand for precision...0 Kommentare 0 Geteilt 106 Ansichten 0 Bewertungen
Weitere Ergebnisse
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali